Thermo Scientific™ CryoMed™ Controlled-Rate Freezer CTS Series

Overview

The Thermo Scientific™ CryoMed™ CTS Series Controlled-Rate Freezer is an engineered solution for critical cryopreservation workflows in cell and gene therapy (CGT), vaccine manufacturing, and advanced biologics development. Based on precise liquid nitrogen (LN₂)–driven cooling kinetics, the system implements programmable, linear or non-linear cooling profiles—ranging from controlled slow freezing (e.g., −1 °C/min for hematopoietic stem cells) to rapid vitrification-compatible ramping—while actively suppressing intracellular ice formation through real-time thermal feedback. Its architecture integrates dual T-type thermocouples for simultaneous chamber and sample temperature monitoring, eliminating thermal lag and enabling true closed-loop control. Designed for regulatory-intensive environments, the CTS platform meets foundational requirements of Good Manufacturing Practice (GMP), adheres to ISO 13485 quality management principles, and supports full traceability under FDA 21 CFR Part 11 via audit-trail-enabled data logging, electronic signatures, and role-based access control.

Key Features

• OPC UA–compliant Ethernet interface for seamless integration into industrial automation ecosystems (e.g., MES, SCADA, LIMS)
• Dual-solenoid LN₂ injection system with predictive maintenance indicators—minimizing unplanned downtime and ensuring consistent cooling reproducibility across high-throughput runs
• Touchscreen UI with intuitive graphical workflow navigation, supporting multi-language display and contextual help overlays
• Onboard event logging with timestamped records of user actions, configuration changes, alarm triggers, and thermal deviations—all exportable in PDF format via USB
• Vapor-phase-compatible chamber design with VHP (vaporized hydrogen peroxide)–resistant insulation and 304 stainless steel construction for cleanroom-grade compatibility
• Three-tier user authentication (Operator, Supervisor, Administrator) with configurable permissions for method editing, run initiation, and audit log review
• Preloaded with six validated freeze-thaw protocols aligned with common CGT and vaccine cell types—including PBMCs, CAR-T cells, dendritic cells, and viral vector–producing HEK293 lines

Sample Compatibility & Compliance

The CryoMed CTS accommodates standard cryogenic storage formats—including internally threaded cryovials (1.0–5.0 mL), cryobags (up to 250 mL), and multi-well plates—within its 48 L chamber volume. Its uniform temperature distribution (< ±0.5 °C spatial deviation at −80 °C, verified by IQ/OQ temperature mapping) ensures batch consistency across heterogeneous sample loads. The system complies with CE marking directives (2014/30/EU EMC, 2014/35/EU LVD) and supports qualification under ICH Q5C (stability testing of biotechnological products) and USP (cryopreservation of cellular therapies). Optional IQ/OQ documentation packages—including on-site installation and operational qualification with thermocouple calibration certificates—are available for facilities subject to FDA, EMA, or PMDA inspections.

Software & Data Management

Data integrity is enforced through Thermo Fisher Connect–compatible PC software, which enables remote run monitoring, protocol validation, and electronic signature capture compliant with 21 CFR Part 11 Subpart B. All logged parameters—including setpoint vs. actual temperature curves, LN₂ consumption rates, valve actuation events, and alarm histories—are stored with immutable timestamps and user identifiers. Audit trails are retained for ≥36 months and support forensic reconstruction of any freeze cycle. Export functionality includes CSV for statistical process control (SPC) analysis and PDF for regulatory submission packages. The system also provides configurable alert thresholds and email/SNMP notifications when deviations exceed predefined limits—supporting proactive quality intervention.

Applications

• Cryopreservation of primary human cells (e.g., T lymphocytes, mesenchymal stromal cells) with defined viability and functional recovery post-thaw
• Process validation of autologous and allogeneic cell therapy manufacturing steps under GMP conditions
• Stability studies for mRNA-LNP formulations and adenoviral vectors requiring ultra-low temperature storage
• Controlled-rate freezing of induced pluripotent stem cell (iPSC) lines to preserve genomic integrity and differentiation potential
• Biobanking operations requiring long-term archival storage with documented chain-of-custody and environmental history

FAQ

Does the CryoMed CTS support 21 CFR Part 11 compliance out of the box?
Yes—the system ships with factory-installed firmware enabling electronic signatures, audit trail generation, and role-based access controls. Full compliance requires site-specific configuration and procedural documentation, supported by Thermo Fisher’s optional Compliance Services.

Can I integrate this freezer into our existing MES using OPC UA?
Yes—OPC UA server functionality is embedded and certified for interoperability with leading MES platforms. Configuration files and node maps are provided in standard XML format for engineering team deployment.

What validation documentation is included with shipment?
All units include a Factory Certificate of Conformance, as-built drawings, electrical schematics, and a completed FAT (Factory Acceptance Test) report. IQ/OQ services are available as add-on engagements.

Is the chamber suitable for vapor-phase LN₂ storage during extended hold periods?
Yes—the insulated chamber and optimized gas flow dynamics maintain stable vapor-phase temperatures down to −150 °C without direct liquid contact, reducing contamination risk and improving sample sterility assurance.

How often does preventive maintenance require LN₂ valve replacement?
The dual-solenoid system includes usage counters and performance diagnostics; typical service intervals range from 12–18 months depending on daily run frequency and profile aggressiveness. Maintenance alerts appear directly on the touchscreen UI.